The hematocrit paradox--how does blood doping really work?

Area of Science:

• Sports Science
• Exercise Physiology
• Biochemistry

Background:

• The common belief is that blood doping, using erythropoietin or transfusions, primarily boosts aerobic performance by increasing hematocrit and thus arterial oxygen content.
• However, this assumption is challenged by the complex physiological responses observed in both natural athletes and those undergoing doping.

Purpose of the Study:

• To investigate the multifactorial mechanisms underlying performance enhancement after blood doping.
• To challenge the simplistic view that increased hematocrit is the sole determinant of improved aerobic capacity.

Main Methods:

• The study reviews existing literature and physiological principles.
• It analyzes the effects of increased hematocrit, blood volume, and other physiological changes on exercise performance.
• It considers potential confounding factors like placebo effects.

Main Results:

• While optimal hematocrit can enhance oxygen delivery, excessively high levels may impede cardiac output due to increased blood viscosity.
• Erythropoietin may improve cardiac power, maintaining cardiac output despite higher viscosity.
• Other contributing factors include enhanced oxygen diffusion, improved red blood cell quality, increased buffer capacity, and potential psychological effects.

Conclusions:

• Blood doping's benefits are multifactorial and extend beyond simple increases in arterial oxygen content.
• The physiological adaptations are complex, involving interactions between blood viscosity, cardiac function, oxygen transport, and other systemic effects.